Evidence map›Paper›PMID 29678970›Full record

Trial reportBMJ open2018

Feasibility of personalised remote long-term follow-up of people with cochlear implants: a randomised controlled trial.

Helen Cullington, Padraig Kitterick, Mark Weal, Magdalena Margol-Gromada

Registry-linked trialAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05973669 (MED-EL Remote Care Multi-Center Feasibility Study), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05973669 nacompletednot on this mapstarted 2024, after this paper: background citation

MED-EL Remote Care Multi-Center Feasibility Study

TypeinterventionalSponsorMed-El CorporationRan2024 to 2026Enrolled53ConditionsHearing Loss, Sensorineural, Cochlear Implant, Cochlear Implant Recipients, Hearing DisordersArmsMED-EL Remote Care
3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Remote assessments for bone conduction hearing devices during the COVID-19 pandemic.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Personal experience with the remote check telehealth in cochlear implant users: from COVID-19 emergency to routine service.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Helen CullingtonUniversity of Southampton Auditory Implant Service, Southampton, UK.ORCID 0000-0002-5093-2020
Padraig KitterickNational Institute for Health Research Nottingham Hearing Biomedical Research Unit, Nottingham, UK.
Mark WealWeb and Internet Science Group, University of Southampton Electronics and Computer Science, Southampton, UK.
Magdalena Margol-GromadaUniversity of Southampton Auditory Implant Service, Southampton, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSubstantial resources are required to provide lifelong postoperative care to people with cochlear implants. Most patients visit the clinic annually. We introduced a person-centred remote follow-up pathway, giving patients telemedicine tools to use at home so they would only visit the centre when intervention was required.

objectivesTo assess the feasibility of comparing a remote care pathway with the standard pathway in adults using cochlear implants.

designTwo-arm randomised controlled trial. Randomisation used a minimisation approach, controlling for potential confounding factors. Participant blinding was not possible, but baseline measures occurred before allocation.

settingUniversity of Southampton Auditory Implant Service: provider of National Health Service care.

participants60 adults who had used cochlear implants for at least 6 months.

interventionsControl group (n=30) followed usual care pathway.Remote care group (n=30) received care remotely for 6 months incorporating: home hearing in noise test, online support tool and self-adjustment of device (only 10 had compatible equipment).

main outcome measuresPrimary: change in patient activation; measured using the Patient Activation Measure.Secondary: change in hearing and quality of life; qualitative feedback from patients and clinicians.

resultsOne participant in the remote care group dropped out. The remote care group showed a greater increase in patient activation than the control group. Changes in hearing differed between the groups. The remote care group improved on the Triple Digit Test hearing test; the control group perceived their hearing was worse on the Speech, Spatial and Qualities of Hearing Scale questionnaire. Quality of life remained unchanged in both groups. Patients and clinicians were generally positive about remote care tools and wanted to continue.

conclusionsAdults with cochlear implants were willing to be randomised and complied with the protocol. Personalised remote care for long-term follow-up is feasible and acceptable, leading to more empowered patients. TRIAL REGISTRATION NUMBER: ISRCTN14644286.

Indexed as

Cochlear ImplantationTelemedicineAdultAftercareAgedAged, 80 and overCanadaCochlear ImplantsCost-Benefit AnalysisFeasibility StudiesFemaleHearing LossHumansMaleMiddle AgedQuality of Lifecochlear implantationcochlear implantshearingpatient-centred caretelemedicine

Identifiers

PMID29678970
PMCPMC5914764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.